Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D3VT
|
||||
Former ID |
DNC013137
|
||||
Drug Name |
Dihydrexidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Phase 1/2 | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C17H17NO2
|
||||
Canonical SMILES |
C1CC2=CC(=C(C=C2C3C1NCC4=CC=CC=C34)O)O
|
||||
InChI |
1S/C17H17NO2/c19-15-7-10-5-6-14-17(13(10)8-16(15)20)12-4-2-1-3-11(12)9-18-14/h1-4,7-8,14,17-20H,5-6,9H2
|
||||
InChIKey |
BGOQGUHWXBGXJW-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 137417-08-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dopamine D1 receptor | Target Info | Inhibitor | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Gap junction | |||||
Dopaminergic synapse | |||||
Parkinson's disease | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Morphine addiction | |||||
Alcoholism | |||||
PANTHER Pathway | Dopamine receptor mediated signaling pathway | ||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
Reactome | Dopamine receptors | ||||
G alpha (s) signalling events | |||||
WikiPathways | Hypothetical Network for Drug Addiction | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Genes and (Common) Pathways Underlying Drug Addiction | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder. Neuropsychopharmacology. 2015 Jan;40(2):446-53. | ||||
REF 2 | J Med Chem. 2006 Nov 16;49(23):6848-57.trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.